top of page

Blood-derived Oncological 
Products

Our Blood-Derived Oncological product line offers a comprehensive selection of human-derived hematological cancer models and related biological materials for advanced oncology research. We provide primary leukemic blasts (e.g., AML, ALL), lymphoma cells, enabling detailed studies of hematological malignancies and metastatic processes.

Additionally, we offer matched peripheral blood mononuclear cells (PBMCs), tumor-infiltrating immune cells, and plasma/serum samples from cancer patients, supporting immuno-oncology studies, biomarker discovery, and personalized therapy evaluations. Our products are available from both healthy donors and patients with well-characterized oncological profiles, facilitating comparative studies and predictive modeling of treatment responses.

bottom of page